Week in Review: Stryker Pays $764 Million for China Orthopedic Maker
Stryker Corporation of the US will acquire a China orthopedic maker, Trauson Holdings, for $764 million in cash; Sanjiu Medical & Pharma acquired a 97% interest in Guilin Tianhe Pharma, an OTC patch products company; China National Biotec, the largest biotech in China, is reported to be planning a $1.5 billion Hong Kong IPO; Yunnan Walvax Biotech paid $49.2 million to acquire a 58% stake in Shanghai Zerun Biotech; Nanjing Micro-Tech, a medical device maker, received an equity investment from Actis; China’s SFDA is considering -reaching changes to its drug approval that will prioritize innovative drugs;  Shenzhen Neptunus Bioengineering filed an application for a US Phase II clinical trial of Polydatin Injection; and Sihuan Pharma received SFDA approval to begin producing an opioid receptor inhibitor. More details…. Stock Symbols: (NYSE: SYK) (HK: 0325) (SHE: 000999) (SHE: 300142) (SHE: 000078) (HK: 0460) Share this with colleagues: // //  
Related Stocks:
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here